Deconstructing psychiatric disorders, part 2 - An emerging, neurobiologically based therapeutic strategy for the modern psychopharmacologist

被引：14

作者：

Stahl, SM

机构：

[1] Neurosci Educ Inst, Carlsbad, CA 92009 USA

[2] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 2003年 / 64卷 / 10期

关键词：

D O I：

10.4088/JCP.v64n1001

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

引用

页码：1145 / 1146

页数：2

共 6 条

[1] Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia [J].

Egan, MF ;

Goldberg, TE ;

Kolachana, BS ;

Callicott, JH ;

Mazzanti, CM ;

Straub, RE ;

Goldman, D ;

Weinberger, DR .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6917-6922

[2] Serotonin transporter genetic variation and the response of the human amygdala [J].

Hariri, AR ;

Mattay, VS ;

Tessitore, A ;

Kolachana, B ;

Fera, F ;

Goldman, D ;

Egan, MF ;

Weinberger, DR .

SCIENCE, 2002, 297 (5580) :400-403

[3] Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease [J].

Shorter, E ;

Tyrer, P .

BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7407) :158-160

[4] Deconstructing psychiatric disorders, part 1 - Genotypes, symptom phenotypes, and endophenotypes [J].

Stahl, SM .

JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (09) :982-983

[5]

Stahl SM, 2003, J CLIN PSYCHIAT, V64, P745

[6]

Stahl SM., 2002, Essential psychopharmacology of antipsychotics and mood stabilizers

← 1 →